These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 10462065)

  • 1. Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators.
    Di Marzo V
    Life Sci; 1999; 65(6-7):645-55. PubMed ID: 10462065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry of the endogenous ligands of cannabinoid receptors.
    Di Marzo V; Deutsch DG
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):386-404. PubMed ID: 9974173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous cannabinoid signaling.
    Piomelli D; Beltramo M; Giuffrida A; Stella N
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):462-73. PubMed ID: 9974178
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study.
    Romero J; Hillard CJ; Calero M; Rábano A
    Brain Res Mol Brain Res; 2002 Apr; 100(1-2):85-93. PubMed ID: 12008024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.
    Bisogno T; Berrendero F; Ambrosino G; Cebeira M; Ramos JA; Fernandez-Ruiz JJ; Di Marzo V
    Biochem Biophys Res Commun; 1999 Mar; 256(2):377-80. PubMed ID: 10079192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Arachidonoyl-glycerol as an "endocannabinoid": limelight for a formerly neglected metabolite.
    Di Marzo V
    Biochemistry (Mosc); 1998 Jan; 63(1):13-21. PubMed ID: 9526090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
    Di Marzo V; Melck D; Bisogno T; De Petrocellis L
    Trends Neurosci; 1998 Dec; 21(12):521-8. PubMed ID: 9881850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments.
    Di Marzo V; De Petrocellis L; Bisogno T; Melck D
    Lipids; 1999; 34 Suppl():S319-25. PubMed ID: 10419192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol.
    Hillard CJ
    Prostaglandins Other Lipid Mediat; 2000 Apr; 61(1-2):3-18. PubMed ID: 10785538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quest for a vascular endothelial cannabinoid receptor.
    Kunos G; Bátkai S; Offertáler L; Mo F; Liu J; Karcher J; Harvey-White J
    Chem Phys Lipids; 2002 Dec; 121(1-2):45-56. PubMed ID: 12505689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges.
    Schmid HH; Schmid PC; Berdyshev EV
    Chem Phys Lipids; 2002 Dec; 121(1-2):111-34. PubMed ID: 12505695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.
    Sugiura T; Kobayashi Y; Oka S; Waku K
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):173-92. PubMed ID: 12052034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for the endogenous cannabinoid system in the peripheral control of pain initiation.
    Calignano A; La Rana G; Loubet-Lescoulié P; Piomelli D
    Prog Brain Res; 2000; 129():471-82. PubMed ID: 11098711
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
    Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
    Reggio PH; Traore H
    Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina.
    Bisogno T; Delton-Vandenbroucke I; Milone A; Lagarde M; Di Marzo V
    Arch Biochem Biophys; 1999 Oct; 370(2):300-7. PubMed ID: 10577359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroscience. Stout guards of the central nervous system.
    Mechoulam R; Lichtman AH
    Science; 2003 Oct; 302(5642):65-7. PubMed ID: 14526067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
    Sugiura T; Kondo S; Sukagawa A; Nakane S; Shinoda A; Itoh K; Yamashita A; Waku K
    Biochem Biophys Res Commun; 1995 Oct; 215(1):89-97. PubMed ID: 7575630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells.
    Basavarajappa BS; Hungund BL
    J Neurochem; 1999 Feb; 72(2):522-8. PubMed ID: 9930723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous cannabinoids: metabolism and their role in reproduction.
    Habayeb OM; Bell SC; Konje JC
    Life Sci; 2002 Mar; 70(17):1963-77. PubMed ID: 12148689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.